Inventor
Gary R. Pasternack
Inventor
Baltimore, MD, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes21%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A01NPreservation of bodies of humans or animals or plants or parts thereof6%
A23BPreservation of foods, foodstuffs or non-alcoholic beverages6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y02ATechnologies for adaptation to climate change4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
PatentTitleYear
10,711,252None20208,685,696'Salmonella bacteriophage and uses thereof'20148,685,697'Listeria monocytogenes bacteriophages and uses thereof'20148,003,323'Reduction in bacterial colonization by administering bacteriophage compositions'20117,745,194'Staphylococcus aureus: bacteriophage and uses thereof'20107,674,467'Salmonella bacteriophage and uses thereof'20107,635,584'E. coli O157:H7 bacteriophage and uses thereof'20097,625,556'E. coli bacteriophage and uses thereof'20097,625,740'Clostridium perfringens bacteriophage and uses thereof'20097,625,739'Clostridium perfringens bacteriophage and uses thereof'20097,625,741'E. coli O157:H7 bacteriophage and uses thereof'20097,622,293'Pseudomonas aeruginosa: bacteriophage and uses thereof'20097,507,571'Listeria monocytogenes bacteriophage and uses thereof'20097,459,272'Reduction in bacterial colonization by administering bacteriophage compositions'20087,385,086'Antimicrobial compounds'20087,374,907'System and method for automatically processing tissue samples'20086,930,175'Gene family with transformation modulating activity'20056,713,654'Antimicrobial compounds'20046,699,701'Method and device for sanitation using bacteriophages'20046,040,173'Nucleic acid encoding a novel mammalian protein associated with uncontrolled cell division'20005,981,575'Inhibition of fatty acid synthase as a means to reduce adipocyte mass'19995,874,234'Assay for a novel mammalian protein associated with uncontrolled cell division'19995,872,217'Antibodies which specifically bind a cancer related antigen'19995,864,011'Cancer related antigen'19995,759,837'Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway'19985,759,791'Cancer related antigen'19985,756,676'Mammalian protein associated with uncontrolled cell division'19985,734,022'Antibodies to a novel mammalian protein associated with uncontrolled cell division'19985,726,018'Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division'19985,665,874'Cancer related antigen'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2000Patents assigned to UNIV JOHNS HOPKINS (11)· patent assignee history
1997–2020Based in Baltimore, MD, US· patent location history
2004–2020Patents assigned to INTRALYTIX INC (15)· patent assignee history
2004–2008Patents assigned to UNIV JOHNS HOPKINS MED (3)· patent assignee history
2008–2014Patents assigned to PASTERNACK GARY (2)· patent assignee history
2008Patents assigned to GIBSON JAY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTRALYTIX INC | 15 | 2004–2020 |
| UNIV JOHNS HOPKINS | 11 | 1997–2000 |
| UNIV JOHNS HOPKINS MED | 3 | 2004–2008 |
| PASTERNACK GARYself | 2 | 2008–2014 |
| GIBSON JAY | 1 | 2008 |
Locations
| Location | Patents | Span |
|---|---|---|
| Baltimore, Maryland, US | 30 | 1997–2020 |